Nyquil

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nyquil

What Type of Medicine is Nyquil?

Nyquil is a recognized brand of synthetic, fixed-dose combination medication, classified as an Over-The-Counter (OTC) product designed for nighttime cold and flu relief. It is categorized as an Upper Respiratory Combination drug administered via the oral route. The medication's multi-component nature is designed to address a spectrum of symptoms through its specific active ingredients. This combination approach allows the medicine to manage various discomforts, focusing its therapeutic positioning on supporting rest and symptom management during the acute phase of illness.


What is the Composition and Purpose of the Nyquil Combination?

The foundational composition of Nyquil includes three distinct pharmacological components: the Analgesic and Antipyretic ingredient Acetaminophen, the Antitussive (cough suppressant) agent Dextromethorphan HBr, and the Sedating Antihistamine Doxylamine Succinate. These compounds are delivered in both an Oral Solution (a hydroalcoholic solution) and Capsules. The combination is intended to provide relief from fever, minor aches, persistent coughing, sneezing, and a runny nose. The primary purpose of this structure is to provide comprehensive, multi-symptom relief to individuals experiencing concurrent cold and flu issues.


Why is Nyquil Considered a Nighttime Formula?

The designation of Nyquil as a nighttime formula centers on the inclusion of Doxylamine Succinate. This first-generation antihistamine is the compound responsible for the drowsy formula effect, which provides a key differentiation from non-sedating daytime cold preparations. The Antitussive agent Dextromethorphan further assists by suppressing the involuntary cough reflex. By coupling symptom relief with an intentional sleep-inducing effect, the product's general purpose is to ensure the facilitation of sleep, which can be compromised by the discomforts of cold and flu.

Regulatory References

  1. NIH DailyMed Drug Listing (Nyquil)

What side effects are possible with Nyquil?

Possible Side Effects and Safety Information

The official regulatory documentation for this combination medication (Acetaminophen, Dextromethorphan, Doxylamine Succinate) outlines its safety profile through expected adverse reactions and mandatory warnings for serious risks.

The most prominent expected effect noted in the labeling is marked drowsiness, which is intrinsic to the sedating antihistamine component. Other frequently documented adverse reactions, generally classified under Nervous System and Gastrointestinal disorders, include dizziness, constipation, dry mouth, nose, or throat, and occasionally excitability, particularly noted in children. The combination's anticholinergic properties may also lead to trouble urinating or blurred vision.

Serious Adverse Reactions

Official labeling highlights the potential for severe reactions. The primary serious risk is severe liver damage (hepatotoxicity), which is associated with the acetaminophen component. This risk is dose-dependent and is explicitly warned against if the maximum daily limit is exceeded or if taken with other acetaminophen products or alcohol. Additionally, rare but serious events such as severe skin reactions (e.g., SJS, TEN) and acute allergic reactions are documented. A critical safety constraint involves the risk of Serotonin Syndrome if the medication is used concomitantly with, or within two weeks of stopping, a prescription Monoamine Oxidase Inhibitor (MAOI).

Population and Dose Constraints

The safety profile includes specific considerations for certain groups: Older adults may be more susceptible to side effects like confusion, dizziness, and urinary issues. Individuals with pre-existing liver disease face an elevated risk of severe liver damage. Regulatory documents mandate consultation with a health professional before use in pregnant or breast-feeding individuals.

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Guidance

The official overdose profile for this combination medication is defined by the toxicological risks of its components, necessitating specific and immediate actions. Immediate medical attention is required for any suspected overdose, as stated in regulatory documents, and individuals must contact emergency services immediately, even if initial symptoms are mild or absent.

Documented overdose manifestations may initially include nausea, vomiting, abdominal pain, and diaphoresis. Central Nervous System (CNS) effects are also listed, such as drowsiness, confusion, agitation, fixed dilated pupils, and nystagmus.

Severe or life-threatening outcomes documented in regulatory sections include Hepatotoxicity potentially leading to Hepatic failure from the Acetaminophen component. Other severe risks are respiratory depression, coma, seizures, and the risk of Serotonin Syndrome. Population-specific notes confirm increased risk for patients with pre-existing hepatic impairment.

Management requires a rapid response. The specific antidote for Acetaminophen toxicity, N-acetylcysteine (NAC), is administered according to protocol. No specific antidote is known for the other components. Symptomatic and supportive treatment is the mandated approach, and hospital monitoring, including Liver Function Tests (LFTs) and plasma concentration measurement, is required for observation and clinical guidance.

Therapeutic Uses of Nyquil

The Nyquil Cold & Flu combination is commonly used for supportive symptomatic assistance in conditions characterized by periods of heightened symptoms associated with the common cold or flu. This product is categorized for use in areas where additional symptomatic support is needed.


What Nyquil Treats: Main Uses and Benefits

This multi-component formula may assist with managing symptoms that interfere with daily comfort, including fever, headache, body aches, persistent coughing, sneezing, and runny nose. One therapeutic benefit of the nighttime formula is its role in supporting the patient's ability to achieve rest. It is commonly used when symptoms that interfere with daily functioning are disruptive during flare-ups and may interfere with the ability to achieve rest. This multi-component formula contributes to improved comfort during symptomatic periods.

“The combination is applied in addressing symptoms related to inflammatory or irritative states in the upper airway.”

Quick Fact: Relief for Concurrent Symptoms
The use of this medication is relevant when multiple symptoms are present simultaneously, and is used to provide supportive relief from systemic discomfort, cough, and nasal distress.

Regulatory References

  1. DailyMed system of the National Library of Medicine

Eligibility and Restrictions for Use

This section outlines the official eligibility and exclusion criteria for NyQuil Cold and Flu, based strictly on government regulatory labeling.

Eligibility Scope

Category Regulatory Status
Allowed Population Adults and children 12 years and over
Conditional Use Children 4 to under 12 years must ask a doctor
Contraindicated Age Children under 4 years must not use

Contraindications and Restrictions

Do Not Use If:

  • You are taking a prescription Monoamine Oxidase Inhibitor (MAOI), or within two weeks of stopping an MAOI.
  • You are taking any other product containing acetaminophen to prevent accidental overdose.
  • You have a known allergy to acetaminophen, dextromethorphan, doxylamine, or any product component.

Ask a Doctor Before Use If You Have:

  • Liver disease.
  • Glaucoma.
  • Breathing problems or a chronic cough (e.g., associated with smoking, asthma, or emphysema).
  • Trouble urinating due to an enlarged prostate gland.
  • You are pregnant or breast-feeding.

What should I know about interactions with other medicines?

NyQuil, which contains Acetaminophen (a pain reliever/fever reducer), Dextromethorphan (a cough suppressant), and Doxylamine (an antihistamine), has several important interactions.

Major Contraindications

Interacting Substance Potential Effect Recommendation
MAO Inhibitors (MAOIs) Risk of life-threatening Serotonin Syndrome (high fever, agitation, confusion). DO NOT USE within 14 days of taking an MAOI (e.g., phenelzine, selegiline).
Other Acetaminophen Products Risk of severe liver damage from exceeding the maximum daily dose. Do not use with Tylenol or other cold/flu remedies containing Acetaminophen.
Alcohol (Ethanol) Increases risk of liver damage (due to Acetaminophen) and excessive drowsiness/sedation (due to Doxylamine and Dextromethorphan). AVOID alcohol completely.

Other Significant Interactions

Combination with other sedatives (e.g., benzodiazepines, opioids, or some antidepressants) or other antihistamines will increase the central nervous system depressant effects, leading to pronounced drowsiness, dizziness, or slowed breathing. Doxylamine also has anticholinergic properties, meaning combining it with other anticholinergic drugs (e.g., certain bladder or psychiatric medicines) can worsen side effects like dry mouth, constipation, or urinary retention. Always consult a healthcare professional or pharmacist before combining NyQuil with any other medication, including prescription, over-the-counter, or herbal supplements.

Mechanism of Action

How Nyquil Works: Mechanism of Action


Modulation of Central Histaminergic Pathways

This mechanism involves the competitive antagonism of the Histamine mathbfH1 Receptor by Doxylamine within the central nervous system (CNS), particularly in arousal centers. This action effectively blocks the neurotransmission of histamine, a key mediator of wakefulness, resulting in pronounced CNS depression and the modulation of the wakefulness state.


Inhibition of Central PGE2 Synthesis

Acetaminophen operates primarily by inhibiting cyclooxygenase (COX) activity in the CNS, which reduces the synthesis and concentration of Prostaglandin E2 ( PGE2) in the hypothalamus. This molecular action directly results in the lowering of the body's thermoregulatory set point, triggering peripheral vasodilation and heat loss, alongside the central modulation of nociceptive signaling pathways.


️ Suppression of the Medullary Cough Center

The antitussive agent Dextromethorphan engages in complex central modulation, primarily involving Sigma-1 (sigma1) receptor agonism and NMDA receptor antagonism within the brainstem's cough center. This dual interaction dampens the center's excitability, resulting in an elevated firing threshold for afferent nerve stimuli, thereby inhibiting the reflex arc.


Mechanistic Integration

The drug's overall profile is shaped by the coordination of these three CNS-focused mechanisms. The intentional CNS depression from the antihistamine acts coordinately with the central modulation of the thermoregulatory/nociceptive pathways and the central inhibition of the cough reflex, leading to the simultaneous dampening of multiple physiological responses.

Dosage and Administration Information

How to Use Nyquil: Official Administration Guidelines

The administration of the Nyquil Cold & Flu combination product (Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate) follows standard product guidelines. The medicine is administered via the oral route in two standardized forms: an Oral Solution and LiquiCaps.


Dosing and Frequency

For individuals 12 years of age and older, the standard single dose consists of 30 mL of the Oral Solution or 2 LiquiCaps. This unit dose provides 650 mg of Acetaminophen, 30 mg of Dextromethorphan HBr, and 12.5 mg of Doxylamine Succinate. Dosing is scheduled on an as-needed basis with a required interval of every 6 hours. The total intake must not exceed 4 doses (120 mL of liquid or 8 LiquiCaps) within any 24-hour period.


Administration and Procedural Rules

Proper administration requires using the dose cup provided with the Oral Solution to ensure accurate volumetric measurement. LiquiCaps must be taken with water. The duration of use is intended for short-term, acute use. Standard usage includes a time limit, which involves stopping administration if cough or pain persists for more than 7 days or if fever lasts more than 3 days, which signals the need for professional consultation.


Age-Specific Use

The product is intended for those 12 years of age and older at the standard dose. For children aged 4 to under 12, the instruction is to ask a doctor before use. The medicine must not be used for children under the age of four.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Nyquil

Research evidence for combination formulas containing an analgesic/antipyretic (Acetaminophen), an antitussive (Dextromethorphan), and a sedating antihistamine (Doxylamine Succinate) is drawn from regulatory reviews, expert literature, and Randomized Controlled Trials (RCTs) used to explore outcomes related to acute respiratory illness symptoms.


Evidence for Multi-Symptom Relief in the Common Cold

Research has been used in trials assessing short-term, episodic symptom patterns associated with the common cold. These studies, including controlled trials and systematic reviews, research examined how multi-component combinations compare to a placebo or to single-ingredient treatments. Findings describe patterns observed in the studies, and studies report how symptoms evolved in the observed populations, indicating differences in patient-reported outcomes compared to those receiving a placebo over the typical, short duration of the common cold. The evidence quality varies across studies.

What remains uncertain is the consistency of the outcomes of the multi-component formula on individual symptoms, as some studies suggest the findings were mixed. The certainty of the evidence for these complex combinations is generally categorized as Moderate.


Evidence for Addressing Systemic Discomfort and Fever

The research base for fever and systemic discomfort stems mainly from studies of the analgesic and antipyretic component (Acetaminophen). This component was studied for its effect on fever and pain in acute influenza-like illnesses. Findings describe patterns observed in these studies where the analgesic/antipyretic component was associated with outcomes related to systemic or functional imbalance (fever) and outcomes related to physical discomfort (pain). Comparative evidence is lacking for the full three-component formula in this context.


Evidence in Special Populations and Research Gaps

Studies primarily included adults and older children. Peer-reviewed systematic reviews have consistently reported a lack of evidence to determine the effects of these preparations in young children (typically those under 6 years of age). This research gap highlights that results apply only to the populations studied, and subgroup findings are uncertain regarding the effect of these formulations in the youngest pediatric age groups.

The research conducted is strictly focused on short-term outcomes, with follow-up durations limited to 3 to 10 days. Therefore, long-term effects are not fully established or studied.

Key Studies & References

  1. Acetaminophen Drug Information - DailyMed

Frequently Asked Questions (FAQ)

Common questions about Nyquil (FAQ)


Q: What is the difference between Nyquil Cold & Flu and Nyquil Severe Cold & Flu?

The official product information indicates that the Severe formula generally includes an extra active component compared to the standard Cold & Flu product. This additional ingredient is typically a nasal decongestant, such as Phenylephrine HCl. This difference is intended to address symptoms of nasal and sinus congestion.


Q: Can Nyquil be used for symptoms other than the common cold, such as allergies?

The product is officially described in regulatory labeling for the temporary relief of common cold and flu symptoms. While it contains an antihistamine, which addresses symptoms like sneezing and runny nose, its official indication is limited to use during acute cold and flu episodes.


Q: Can I take Nyquil if I am also taking an over-the-counter pain reliever like Tylenol (acetaminophen)?

Regulatory documents provide a clear instruction not to use this product with any other medications, whether prescription or nonprescription, that contain acetaminophen. This is an important safety constraint intended to prevent users from exceeding the maximum daily limit for acetaminophen, which could lead to severe liver damage.


Q: Can Nyquil cause a feeling of 'foggy' thinking the next morning?

The official safety information indicates that the sedating ingredient in the product can cause marked drowsiness and dizziness. These are documented side effects. For this reason, official warnings advise caution when performing activities that require alertness, such as driving or operating machinery.


Q: What research exists about the long-term or repeated use of Nyquil?

Studies and research reviews examining combination formulas of this type focus strictly on short-term outcomes, typically over periods of 3 to 10 days. The official research literature reports that the long-term effects of repeated or extended use of these preparations are not fully established or studied.


Q: Why do some people report an increase in anxiety or restlessness after taking it?

Regulatory documentation lists excitability as a possible adverse reaction to the product, especially in certain populations such as children. This documented effect is considered a central nervous system effect described in regulatory labeling.


Q: How long does the primary sleepiness effect from Nyquil typically last?

The length of the sleepiness effect is not precisely detailed in patient-facing documents. However, official administration instructions specify that the medicine may be taken every six hours, which is the required interval between doses.


Q: Can I take Nyquil if I have high blood pressure?

Regulatory documents advise that individuals who have high blood pressure should consult a healthcare professional before using certain NyQuil formulations. This caution is often specific to products that contain a nasal decongestant ingredient.


Q: What happens if I accidentally take Nyquil during the day?

Regulatory warnings advise of marked drowsiness and the need for caution when driving or operating machinery after using the product. These warnings are based on the sedating effect of one of the active ingredients, and they apply regardless of the time of day the medicine is taken.


Q: Is there a version of Nyquil that does not cause drowsiness?

Official labeling for cold relief combination kits often includes a non-drowsy daytime component, typically sold under the DayQuil brand name. The key difference in these daytime formulas is the omission of the sedating antihistamine component present in the nighttime Nyquil product.


Q: Are there any documented research summaries on the effectiveness of the ingredients in Nyquil?

Research evidence from controlled trials has been used to examine the patterns of short-term multi-symptom relief in people experiencing common cold symptoms. The certainty of the evidence regarding the complex combination formula's effectiveness is generally categorized as Moderate.


Q: Does Nyquil interact with any common herbal supplements?

Official guidance advises consulting a healthcare professional or pharmacist before combining the product with any other medication. This precaution applies to prescription and over-the-counter medicines, as well as herbal supplements.


Q: Can Nyquil be used for the flu, or is it only intended for a cold?

The product is officially indicated for the temporary relief of both common cold and flu symptoms. This includes symptoms such as minor aches, fever, cough, and runny nose, as described in the official 'Uses' section of the labeling.


Q: Are there specific food items or beverages that should be avoided while using Nyquil?

Regulatory labeling explicitly advises users to avoid alcoholic drinks while using the product. This warning is due to the potential for increased risk of liver damage from acetaminophen and excessive drowsiness due to the sedating ingredients.


Q: Does Nyquil affect blood sugar levels, and is it suitable for someone with diabetes?

Regulatory documents advise individuals with diabetes to consult a healthcare professional before use. This consultation is recommended to ensure appropriate use. Specific formulations of the product are also marketed for use by individuals with diabetes.


Q: Does Nyquil contain aspirin or NSAIDs?

The official list of active ingredients includes Acetaminophen, Dextromethorphan HBr, and Doxylamine Succinate. Based on this labeling, the product does not contain aspirin or other common nonsteroidal anti-inflammatory drugs (NSAIDs).


Q: Is it possible to have an allergic reaction to Nyquil's inactive ingredients?

The official allergy warning advises users not to use the product if they have a known allergy to the active ingredients or any product component. This warning covers both the active ingredients and the inactive components of the formulation.


Q: Are there specific populations for whom the research evidence is limited or different?

Research literature reports that the evidence used to determine the effects of these preparations is notably limited for young children, typically those under 6 years of age. Therefore, the findings from clinical studies primarily apply to adults and older children.

How should Nyquil be stored and disposed of?

The official product labeling requires NyQuil to be stored at controlled room temperature, generally defined as between 20 C and 25 C (68 F and 77 F). The medication must not be refrigerated or frozen, as these conditions can compromise product stability.

Protection from environmental factors is also required; the product must be kept out of excessive heat, light, and moisture, and the container should remain tightly closed. As a mandatory safety requirement, the medicine must be stored out of the reach of children.

For disposal, NyQuil is not listed on the FDA's flush list. Unused or expired medication should be mixed with an unappealing substance, such as dirt or used coffee grounds, sealed in a bag or container, and then discarded in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nyquil found in:

A-Z Index: